Abstract

Background: The incidence and distribution of unexpected antibody screening test has been evaluated with Caucasian RBC panel cell. In spite of high incidence of Dia and Mia antigen phenotype in Korea-Mongoloid and south-east population respectively, there has been no documented research on the incidence of anti-Dia and anti-Mia in Korea particularly. To investigate the frequencies and clinical significance of unexpected antibody, screening test including Dia and Mia panel cell was performed.

Method: We analyzed the result from 17,664 antibody screening tests performed during recent 30 month period (March 2001–Sep 2003). Antibody screening and identification test are performed using Liss/Coombs gel test with DiaMed-ID system (DiaMed AG, Cressier, Morat, Switzerland) including Dia and Mia panel cell. The incidence of Dia and Mia phenotype was simultaneously evaluated.

Results: The incidence of unexpected antibodies was 1.2% (214/17,664). Antibodies that were detected most frequently were anti-Rh (74 patient), followed by anti-Lewis (21 patient) and anti-Dia (15 patients). Out of 6345 patients, 3 anti-Mia (0.047%) were detected. Antibodies of Dia and Mia were IgG specificity and anti-Dia was immune antibody, anti-Mia was mixed with immune and natural antibodies. The frequencies of Dia and Mia phenotye were 12.2% and 0.93% respectively.

Conclusion: This study shows that anti-Dia and Mia antibodies are detected frequently for Korean. For safer transfusions, therefore, Dia and Mia panel cell should be also included in antibody screening test for Korean.

Author notes

Corresponding author